Testing effectiveness (Phase 2)Study completedNCT02384317
What this trial is testing
Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade
Who this might be right for
Immunoglobulin A Nephropathy
Amgen 7